We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+17.96%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$439M
AUM Growth
-$225M
Cap. Flow
-$271M
Cap. Flow %
-61.73%
Top 10 Hldgs %
45.18%
Holding
219
New
28
Increased
28
Reduced
52
Closed
34

Top Buys

Rank Stock Value
1
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$7.26M
2
GSAH.U
GS Acquisition Holdings Corp II Units, each consisting of one share of Class A Common Stock and one-
GSAH.U
+$5.54M
3
LM
Legg Mason, Inc.
LM
+$5.11M
4
WUBA
58.com Inc
WUBA
+$3.71M
5
MEET
The Meet Group, Inc. Common Stock
MEET
+$2.44M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$48.9M
2
S
Sprint Corporation
S
+$33.6M
3
CY
Cypress Semiconductor
CY
+$29.2M
4
WBC
WABCO HOLDINGS INC.
WBC
+$26M
5
MLNX
Mellanox Technologies, Ltd.
MLNX
+$22.6M

Sector Composition

Rank Sector Weight
1 Financials 19.16%
2 Technology 13.89%
3 Consumer Discretionary 8.13%
4 Healthcare 7.58%
5 Utilities 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLLCR
201
DELISTED
Fellazo Inc. Right
FLLCR
– –
-145,800
Closed -$22K
KEM
202
DELISTED
KEMET Corporation
KEM
– –
-304,755
Closed -$7.36M
CY
203
DELISTED
Cypress Semiconductor
CY
– –
-1,253,619
Closed -$29.2M
5 6 7 8
9

Similar funds

RCM
Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return
DPC
Dream Peak Capital Hong Kong $675M AUM
BFA
Blueprint Financial Advisors Greensboto, North Carolina $675M AUM 24.91% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CHCM
Columbus Hill Capital Management Short Hills, New Jersey $673M AUM 24.63% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Gabelli & Co Investment Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Gabelli & Co Investment Advisers held 219 positions worth $439M, down 34% from $664M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $271M in Q2 2020, closing 34 positions and reducing 52 holdings. Its most notable exit was Allergan plc, an estimated $48.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 11% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Gabelli & Co Investment Advisers opened a new position in Portola Pharmaceuticals, Inc. worth $9.39M.

  • Gabelli & Co Investment Advisers's largest Q2 2020 buy was Portola Pharmaceuticals, Inc.: 521,822 shares worth $9.39M.
  • Gabelli & Co Investment Advisers added most to Legg Mason, Inc. in Q2 2020, an estimated $5.11M increase.
  • Gabelli & Co Investment Advisers's biggest Q2 2020 reduction was Tech Data Corp, cutting an estimated $6.65M.
  • Gabelli & Co Investment Advisers fully exited Allergan plc in Q2 2020, selling an estimated $48.9M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 45% of its $439M portfolio in Q2 2020.
  • Gabelli & Co Investment Advisers opened 28 new positions and closed 34 in Q2 2020.
  • Gabelli & Co Investment Advisers's portfolio value fell 34% quarter-over-quarter to $439M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.